Pharma and BioTech Daily

Navigating the Complexities of Pharma and Biotech: A Daily Overview


Listen Later

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.The FDA is pushing new guidelines for cancer trials, recommending overall survival as a primary endpoint. Capricor Therapeutics is asking the FDA to reconsider their rejection of a treatment for DMD cardiomyopathy with the return of Vinay Prasad. Rocket Pharmaceuticals' phase II trial has resumed after a patient death, and the Trump administration's tariffs and drug pricing policies are causing confusion in the pharmaceutical industry. Fedegari is now offering customized solutions for the bio/pharmaceutical industry. The American Academy of Pediatrics is recommending the COVID-19 vaccine for kids, and there are updates on various biotech developments. Opinion pieces discuss drug pricing and the viability of high-dose peptides.The American pharmaceutical industry has lost the trust of the people, with many viewing them as the 'bad guys' despite producing drugs in the U.S. for Americans. The industry faces challenges such as competition and changing regulations, with the Trump administration's trade policies adding to the confusion. Some companies are taking a platform strategy approach to drug development, using one molecule to target multiple diseases. Despite these challenges, there are opportunities for innovation and growth in the industry. Additionally, conflicts of interest in vaccine committees have been decreasing, and companies are making strategic moves such as forming partnerships and restructuring to adapt to the changing landscape. The industry continues to navigate uncertainty and seek ways to improve drug development and access for patients.
...more
View all episodesView all episodes
Download on the App Store

Pharma and BioTech DailyBy Pharma and BioTech News

  • 3.6
  • 3.6
  • 3.6
  • 3.6
  • 3.6

3.6

11 ratings


More shows like Pharma and BioTech Daily

View all
WSJ Tech News Briefing by The Wall Street Journal

WSJ Tech News Briefing

1,646 Listeners

NPR News Now by NPR

NPR News Now

14,199 Listeners

WSJ Your Money Briefing by The Wall Street Journal

WSJ Your Money Briefing

1,713 Listeners

Planet Money by NPR

Planet Money

30,695 Listeners

Bloomberg Businessweek by Bloomberg

Bloomberg Businessweek

429 Listeners

WSJ Minute Briefing by The Wall Street Journal

WSJ Minute Briefing

662 Listeners

Equity by TechCrunch, Rebecca Bellan, Kirsten Korosec, Anthony Ha, Max Zeff, Theresa Loconsolo

Equity

339 Listeners

The Long Run with Luke Timmerman by Timmerman Report

The Long Run with Luke Timmerman

122 Listeners

The Indicator from Planet Money by NPR

The Indicator from Planet Money

9,514 Listeners

The Readout Loud by STAT

The Readout Loud

316 Listeners

The Journal. by The Wall Street Journal & Spotify Studios

The Journal.

5,960 Listeners

BioCentury This Week by BioCentury

BioCentury This Week

30 Listeners

Biotech Hangout by Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more

Biotech Hangout

17 Listeners

The Wall Street Skinny by Kristen and Jen

The Wall Street Skinny

214 Listeners

WSJ's Take On the Week by The Wall Street Journal

WSJ's Take On the Week

127 Listeners